Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Interparfums Interim / Quarterly Report 2025

Feb 25, 2026

1445_iss_2026-02-25_18ad9cc4-da01-43fd-9b6f-329dec1a2b0d.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

INTERPARFUMS SA

CertiDox

2025 results

Solid performance in an unstable environment

Operating margin: 19.5% - Net margin: 14.1% - Dividend per share: €1.05

Despite 2025 being marked by many external factors that negatively impacted its business, including a turbulent geopolitical and macroeconomic environment, a very unfavorable euro/dollar exchange rate and the introduction of tariffs in the United States, Interparfums posted strong results with still high margins.

Income statement(1) - €m 2023 2024 2025 25/24
Sales 798.5 880.5 899.4 +2%
Gross margin 525.0 577.8 582.1 +1%
% of sales 65.8% 65.6% 64.7%
Operating income 165.6 178.0 175.2 -2%
% of sales 20.7% 20.2% 19.5%
Net income attributable to owners of the parent 118.7 129.9 126.6 -3%
% of sales 14.9% 14.8% 14.1%

Although the 2025 gross margin fell by nearly a point compared to fiscal year 2024, this was attributed entirely to the introduction of tariffs in the United States, given that hedging set up at the beginning of the year helped limit the currency effect on the gross margin.

In 2025, Interparfums continued to focus its investments on the steady development of its brands, with nearly €192 million – more than 21% of its sales – spent on marketing and advertising. Against this backdrop, 2025 operating income, which includes a total impact of €7.6 million in tariffs, was down only slightly thanks to overall cost control. Excluding tariffs, pro forma operating income rose nearly 3% to €182.8 million, bringing the restated operating margin to 20.3%, stable compared to 2024.

Just as net financial income/expense was mainly impacted by the cost of hedging and financial debt, net income followed the same trend. Excluding tariffs, pro forma net income was €132.3 million, 2% higher than in 2024, bringing the net margin to 14.7%, also stable compared to 2024.

Balance sheet(1) - €m 12/31/23 12/31/24 12/31/25 25/24
Inventory 202.4 229.7 197.2 -14%
Cash and cash equivalents 177.7 190.6 204.5 +7%
Shareholders' equity 644.0 699.0 732.0 +5%
Borrowings & financial liabilities 123.0 133.4 141.2 +6%

The return to shorter procurement times over the past several quarters led to a significant reduction in inventories, which were at more normative levels at December 31, 2025, thereby contributing to a positive change in operating cash flow. The Group's financial position remains very strong, with €63 million in cash net of borrowings and financial liabilities and €732 million in shareholders' equity, representing nearly 70% of the balance sheet at December 31, 2025.

Dividend and bonus share issue

On February 24, 2026, the company's Board of Directors approved the 2025 financial statements and decided to propose to the Combined Shareholders' Meeting of April 24, 2026 a dividend of €1.05 per share(2), stable(3) compared with last year, thanks to a payout ratio of nearly 70% of net income for the year. In keeping with a practice introduced in 1999, a new bonus share grant will also be proposed in June for the 27th straight year.

Board of Directors

On the recommendation of the Governance, Nominations and Compensation Committee, the company's Board of Directors decided to propose to the Combined Shareholders' Meeting of April 24, 2026:

  • the appointment of Natalie Bader Messian as independent director for a four-year period following her co-option in September 2025 to replace Véronique Morali;
  • renewal of the terms of Constance Benqué and Olivier Mauny for three more years, as part of the staggering of terms of office.

As was the case last year, following the Shareholders' Meeting, the company's Board of Directors will consist of eight directors, including four women and four men, five independent members and three non-independent members, thereby maintaining the two-fold objective in terms of gender equality and independence, first achieved in April 2022. On that date, the Audit Committee, the Governance, Nominations and Compensation Committee and the CSR Committee will also continue to be made up entirely of independent members, 67% of whom will be women.

Corporate social responsibility

In 2025, Interparfums have continued its efforts in environmental subjects, which resulted in an improvement in all its extra-financial ratings, including MSCI, Sustainalytics, EcoVadis and EthiFinance. The company's decarbonization pathway was also validated by the SBTi (Science Based Targets initiative).

In addition, employee-related initiatives were bolstered with the introduction of the following benefits in 2025:

  • A fourth performance share plan for all employees worldwide;
  • Additional profit-sharing for all employees in France in line with previous years.

Q1 2026 outlook

Activity in the first quarter of 2026 will be impacted by a high basis of comparison resulting from:

  • The unfavorable trend in the euro/dollar exchange rate between Q1 2025 (1.05 on average) and Q1 2026 (expected to be around 1.18), with the percentage of sales in dollars exceeding 50% in 2025;
  • The intense launch program in late 2024 and early 2025;
  • A later launch program in 2026.

Paris, February 25, 2026

(1) Audit procedures carried out and audit report being prepared
(2) Ex-dividend date May 5, 2026 (12:00 a.m.) - Payment date May 7, 2026
(3) Given the June 2025 bonus share grant

Philippe Benacin, Chairman and Chief Executive Officer, said: "Despite an unstable environment, 2025 ended up being a good year in terms of both business development and results. But it was also a very good year in terms of strategy with the integration of three new brands, each of which has significant development potential in its universe. The current economic climate still limits our visibility for 2026 but in no way diminishes our confidence for the following years."

Philippe Santi, Executive Vice President, added: "The 2025 results confirm, once again, the full relevance and flexibility of the company's business model, despite market uncertainties. In 2026, given the numerous launches scheduled for 2027 and 2028, for which preparations are being made this year, Interparfums plans to increase its investments and related expenditures, while maintaining a high operating margin based on the current euro/dollar exchange rate."

Interparfums

10 rue de Solférino

75007 Paris

+33 (0)1 53 77 00 00

This press release is available in French and English on the company's website interparfums-finance.fr

Investor Relations and Analysts Contact

Philippe Santi

Executive Vice President

[email protected]

Nicolas Picaud

Investor Relations Manager

[email protected]

Press Contact

Cyril Levy-Pey

Communication Director

[email protected]

ITP LISTED EURONEXT

ISIN: FR0004024222-ITP

Reuters: IPAR.PA

Bloomberg: ITP

Euronext Compartment A

Eligible for Deferred

Settlement Service (SRD)

Eligible for PEA

Index - SBF 120, CAC Mid 60


Consolidated financial statements

Consolidated income statement

(€ thousands) 2024 2025
Sales 880,493 899,383
Cost of sales (302,706) (317,250)
Gross margin 577,787 582,133
% of sales 65.6% 64.7%
Selling expenses (364,621) (371,402)
Administrative expenses (34,886) (35,497)
Current operating income 178,280 175,234
% of sales 20.2% 19.5%
Other operating expenses (3,700)
Other operating income 3,469
Operating profit 178,049 175,234
% of sales 20.2% 19.5%
Financial income 6,970 4,641
Gross cost of debt (6,757) (5,801)
Net cost of debt 214 (1,160)
Other financial income 9,123 21,022
Other financial expenses (13,133) (29,085)
Net financial income/(expense) (3,796) (9,223)
Income before tax 174,253 166,011
% of sales 19.8% 18.5%
Income tax (44,391) (39,816)
Tax rate 25.5% 24.0%
Share of profit from equity-accounted companies 425 831
Net income 130,287 127,027
% of sales 14.8% 14.1%
Share attributable to non-controlling interests 419 457
Net income attributable to owners of the parent 129,868 126,569
% of sales 14.7% 14.1%
Net earnings per share in euros (1) 1.70 1.58
Diluted earnings per share in euros (1) 1.70 1.58

(1) Restated on a prorated basis for bonus share issues.


Consolidated balance sheet

| ASSETS
(€ thousands) | 2024 | 2025 |
| --- | --- | --- |
| Non-current assets | | |
| Trademarks and other intangible assets | 240,397 | 251,377 |
| Property, plant and equipment | 143,763 | 154,268 |
| Right-of-use assets | 13,226 | 12,700 |
| Long-term investments | 2,656 | 2,830 |
| Non-current financial assets | 2,654 | 897 |
| Equity-accounted investments | 12,893 | 13,213 |
| Deferred tax assets | 20,964 | 17,903 |
| Total non-current assets | 436,553 | 453,187 |
| Current assets | | |
| Inventory and work-in-progress | 229,722 | 197,222 |
| Trade receivables and related accounts | 164,198 | 168,507 |
| Other receivables | 11,515 | 16,430 |
| Corporate income tax | 294 | 9,541 |
| Current financial assets | 7,561 | 3,285 |
| Cash and cash equivalents | 183,077 | 201,210 |
| Total current assets | 596,367 | 596,195 |
| Total assets | 1,032,919 | 1,049,382 |
| SHAREHOLDERS’ EQUITY AND LIABILITIES
(€ thousands) | 2024 | 2025 |
| --- | --- | --- |
| Shareholders’ equity | | |
| Share capital | 228,349 | 251,385 |
| Additional paid-in capital | — | 1,919 |
| Reserves | 338,805 | 350,110 |
| Net income for the year | 129,868 | 126,569 |
| Total shareholders’ equity attributable to owners of the parent | 697,022 | 729,984 |
| Non-controlling interests | 1,536 | 1,700 |
| Total shareholders’ equity | 698,558 | 731,684 |
| Non-current liabilities | | |
| Provisions for non-current expenses | 4,791 | 4,263 |
| Non-current borrowings and financial liabilities | 95,912 | 96,109 |
| Non-current lease liabilities | 10,821 | 7,848 |
| Deferred tax liabilities | 6,507 | 7,313 |
| Total non-current liabilities | 118,031 | 115,534 |
| Current liabilities | | |
| Trade payables and related accounts | 105,249 | 96,556 |
| Current borrowings and financial liabilities | 37,518 | 45,116 |
| Current lease liabilities | 3,219 | 3,215 |
| Provisions for contingencies and expenses | — | — |
| Corporate income tax | 8,034 | 1,549 |
| Other liabilities | 62,311 | 55,728 |
| Total current liabilities | 216,331 | 202,164 |
| Total shareholders’ equity and liabilities | 1,032,919 | 1,049,382 |


Consolidated statement of cash flows

(€ thousands) 2024 2025
Cash flows from operating activities
Net income 130,287 127,027
Depreciation, provisions for impairment and other 22,460 30,632
Share of profit from equity-accounted companies (425) (831)
Net cost of debt 2,971 4,561
Tax expense for the period 44,391 39,816
Cash flows from operations before interest and tax 199,683 201,204
Interest paid and received (430) (1,184)
Tax paid (47,854) (53,997)
Cash flows from operations after interest and tax 151,399 146,023
Changes in inventories and work-in-progress (19,301) 23,332
Change in trade receivables and related accounts (20,734) (12,523)
Change in other receivables (1,059) (10,254)
Change in trade payables and related accounts (10,094) (3,354)
Change in other liabilities 7,498 6,794
Change in working capital requirements (43,690) 3,995
Net cash flows provided by (used in) operating activities 107,709 150,017
Cash flows from investing activities
Net acquisitions of intangible assets (16,173) (21,678)
Net acquisitions of property, plant and equipment (2,683) (18,540)
Net acquisitions of right-of-use assets (1,672) (324)
Acquisition of equity interests (1,988)
Net acquisitions of financial assets 2,998 1,048
Change in long-term investments (633) (116)
Net cash flows provided by (used in) investing activities (18,162) (41,598)
Cash flows from financing activities
Issuance of borrowings and new financial debt 40,000 50,000
Loan repayments (29,635) (42,244)
(Issuance)/repayment of loan granted to stakeholders 27,972
Net change in lease liabilities (1,424) (2,874)
Dividends paid (80,333) (87,620)
Own shares 213 (372)
Financial income/(expense) (2,004) (4,603)
Net cash flows provided by (used in) financing activities (45,211) (87,713)
Impact of conversion rates 1,008 (2,597)
Effect of changes in scope of consolidation 23
Change in net cash 45,344 18,133
Opening cash and cash equivalents 137,734 183,077
Closing cash and cash equivalents 183,077 201,210

The reconciliation of net debt breaks down as follows:

(€ thousands) 2024 2025
Cash and cash equivalents 183,077 201,210
Current financial assets 7,561 3,285
Cash and current financial assets 190,638 204,495
Current borrowings and financial liabilities (37,518) (45,116)
Non-current borrowings and financial liabilities (95,912) (96,109)
Total gross debt (133,430) (141,225)
Net debt 57,208 63,270